Hideyuki Okano visits HSCI on tour of Boston biomedical ecosystem

September 12, 2018

Hideyuki Okano HSCI
Hideyuki Okano shares research progress with HSCI scientists. Photo by Jessica Lau/HSCI.


The Harvard Stem Cell Institute (HSCI) was pleased to host Hideyuki Okano, M.D., Ph.D. on his tour of the Boston biomedical ecosystem in September 2018. Okano, a physiology professor and former dean at the Keio University School of Medicine in Japan, is a leading expert in induced pluripotent stem cell (iPSC) technology and nervous system diseases.

In a seminar at HSCI co-sponsored by the Brigham and Women’s Hospital Division of Renal Medicine, scientists from across Boston and Cambridge discussed the latest progress in neurological disease research. Okano’s talk focused on using iPSCs in spinal cord injury and amyotrophic lateral sclerosis (ALS) from the perspectives of cell therapy, disease modeling, and drug screening.

This was one of several stops on Okano’s tour of the Boston biomedical hub, which included several research institutions and biotechnology companies. It was a perfect example of international knowledge exchange in the rapidly moving field of regenerative medicine.